EP3740504
CD70 samsett meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.1.2019EP published:
19.7.2023EP application number:
19702014.2
EP translation filed:
18.9.2023Grant published:
15.10.2023EPO information:
European Patent Register
Max expiry date:
15.1.2039Expiry date:
15.1.2027Next due date:
31.1.2027
Title in English:
CD70 COMBINATION THERAPYLanguage of the patent:
English
Timeline
Today
16.1.2019EP application
19.7.2023EP Publication
18.9.2023Translation submitted
15.10.2023Registration published
15.1.2027Expires
Owner
Name:
Argenx BVBAAddress:
Industriepark Zwijnaarde 7 Building C, 9052 Gent, BE
Inventor
Name:
VAN ROMPAEY, LucAddress:
9052 Zwijnaarde, BE
Name:
DELAHAYE, TimAddress:
9052 Zwijnaarde, BE
Name:
MOSHIR, MahanAddress:
9052 Zwijnaarde, BE
Name:
ZABROCKI, PiotrAddress:
9052 Zwijnaarde, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201800649Date:
16.1.2018Country:
GB
Classification
Categories:
C07K 16/28, A61P 35/00, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 20.12.2023
Expires: 15.1.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.1.2025
Expires: 15.1.2026
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.1.2026
Expires: 15.1.2027
Payer: Árnason Faktor ehf.